ATE258061T1 - Tri-, tetra-, penta- und polypeptide und ihre therapeutische verwendung als antidepressiva - Google Patents

Tri-, tetra-, penta- und polypeptide und ihre therapeutische verwendung als antidepressiva

Info

Publication number
ATE258061T1
ATE258061T1 AT95923659T AT95923659T ATE258061T1 AT E258061 T1 ATE258061 T1 AT E258061T1 AT 95923659 T AT95923659 T AT 95923659T AT 95923659 T AT95923659 T AT 95923659T AT E258061 T1 ATE258061 T1 AT E258061T1
Authority
AT
Austria
Prior art keywords
residues
penta
polypeptides
tetra
tri
Prior art date
Application number
AT95923659T
Other languages
English (en)
Inventor
Henry B Abajian
John F Noble
Joseph J Hlavka
Original Assignee
Innapharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innapharma Inc filed Critical Innapharma Inc
Application granted granted Critical
Publication of ATE258061T1 publication Critical patent/ATE258061T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT95923659T 1994-05-04 1995-05-02 Tri-, tetra-, penta- und polypeptide und ihre therapeutische verwendung als antidepressiva ATE258061T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/238,089 US5589460A (en) 1994-05-04 1994-05-04 Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
PCT/US1995/005560 WO1995030430A1 (en) 1994-05-04 1995-05-02 Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent

Publications (1)

Publication Number Publication Date
ATE258061T1 true ATE258061T1 (de) 2004-02-15

Family

ID=22896449

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95923659T ATE258061T1 (de) 1994-05-04 1995-05-02 Tri-, tetra-, penta- und polypeptide und ihre therapeutische verwendung als antidepressiva

Country Status (16)

Country Link
US (1) US5589460A (de)
EP (1) EP0759772B1 (de)
JP (1) JP3878983B2 (de)
CN (1) CN1150028C (de)
AT (1) ATE258061T1 (de)
AU (1) AU685292B2 (de)
CA (1) CA2189145C (de)
DE (1) DE69532470T2 (de)
DK (1) DK0759772T3 (de)
ES (1) ES2215175T3 (de)
FI (1) FI964363A7 (de)
MY (1) MY113407A (de)
NO (1) NO317919B1 (de)
PT (1) PT759772E (de)
RU (1) RU2182910C2 (de)
WO (1) WO1995030430A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6767897B2 (en) * 1994-05-04 2004-07-27 Innapharma, Inc. Therapeutic uses of tri-, tetra-, penta-, and polypeptides
US6093797A (en) * 1994-05-04 2000-07-25 Innapharma, Inc. Tri-, Tetra-, Penta-, and polypeptides and their therapeutic use as an antidepressant agent
US5767083A (en) * 1994-05-04 1998-06-16 Innapharma, Inc. Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
US5792466A (en) * 1996-12-13 1998-08-11 The United States Of America, As Represented By The Secretary Of Agriculture Mimetic insect kinin analogs for insect control
AU8912698A (en) * 1997-08-19 1999-03-08 University Of Medicine And Dentistry Of New Jersey Inhibition of hiv-1 replication using d-amino acid peptides
US6150420A (en) * 1998-06-01 2000-11-21 Theramax, Inc. Method for enhanced brain delivery of bupropion
RU2249453C1 (ru) * 2003-07-15 2005-04-10 Боев Игорь Викторович Способ комбинированного купирования депрессивных синдромов субпсихотического уровня эндогенного генеза в условиях дневного стауионара
JP4654418B2 (ja) * 2004-03-31 2011-03-23 独立行政法人産業技術総合研究所 上皮系細胞増殖促進剤
CA2728122C (en) * 2007-06-27 2017-07-25 The Board Of Trustees Of The Leland Stanford Junior University Oligopeptide tyrosinase inhibitors and uses thereof
CN101795703B (zh) 2007-06-27 2015-05-06 里兰斯坦福初级大学理事会 肽酪氨酸酶抑制剂及其应用
CN101284868A (zh) * 2008-05-26 2008-10-15 刘刚 一种肽水合盐类化合物及其立体异构体
CN108690121B (zh) * 2017-04-07 2020-05-15 深圳翰宇药业股份有限公司 一种奈米非肽液相制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3708593A (en) * 1971-08-24 1973-01-02 Abbott Lab Use of l-prolyl l-leucyl glycine amide as an anti-depressant
US3821188A (en) * 1972-06-14 1974-06-28 American Home Prod Proline and pyroglutamic acid containing tripeptides
US3795738A (en) * 1972-12-26 1974-03-05 Abbott Lab Use of l-propyl l-leucyl glycine amide to treat parkinson's disease
US3931184A (en) * 1974-10-31 1976-01-06 Abbott Laboratories Purification method for prolyl-leucylglycinamide
US4018912A (en) * 1975-07-28 1977-04-19 Ayerst Mckenna And Harrison Ltd. Tripeptide derivatives with central nervous system activity and preparation thereof
US4278595A (en) * 1979-12-10 1981-07-14 Vega Laboratories, Inc. Orally active MIF analogs with an effect on the central nervous system
JPS5830299B2 (ja) * 1981-10-30 1983-06-28 三菱化学株式会社 トリペプチドおよびその誘導体
DE3226241A1 (de) * 1982-07-14 1984-01-26 Basf Ag, 6700 Ludwigshafen N-acylderivate von peptiden, ihre herstellung und verwendung bei der bekaempfung von krankheiten und mittel dafuer
JPH06506941A (ja) * 1991-04-24 1994-08-04 ワーナー−ランバート・コンパニー α−置換アミノ酸含有ＣＣＫ類似体
JP3349528B2 (ja) * 1992-08-14 2002-11-25 株式会社日清製粉グループ本社 ペプチド

Also Published As

Publication number Publication date
JPH10500407A (ja) 1998-01-13
AU685292B2 (en) 1998-01-15
EP0759772A4 (de) 1999-04-21
EP0759772A1 (de) 1997-03-05
EP0759772B1 (de) 2004-01-21
FI964363L (fi) 1996-12-23
CA2189145C (en) 2008-03-18
NO964561D0 (no) 1996-10-28
ES2215175T3 (es) 2004-10-01
PT759772E (pt) 2004-06-30
CN1150028C (zh) 2004-05-19
DE69532470D1 (de) 2004-02-26
MY113407A (en) 2002-02-28
NO964561L (no) 1996-12-27
DE69532470T2 (de) 2004-10-21
US5589460A (en) 1996-12-31
FI964363A0 (fi) 1996-10-29
WO1995030430A1 (en) 1995-11-16
RU2182910C2 (ru) 2002-05-27
JP3878983B2 (ja) 2007-02-07
CA2189145A1 (en) 1995-11-16
AU2813995A (en) 1995-11-29
DK0759772T3 (da) 2004-06-01
FI964363A7 (fi) 1996-12-23
CN1151700A (zh) 1997-06-11
NO317919B1 (no) 2005-01-03

Similar Documents

Publication Publication Date Title
ATE258061T1 (de) Tri-, tetra-, penta- und polypeptide und ihre therapeutische verwendung als antidepressiva
DE69326064D1 (de) Peptide des menschlichen Proteins P53 zum Gebrauch in menschlichen-zytotoxischen-T-Zell-Antwort-induzierenden Kompositionen sowie menschliche P53-Protein-spezifische T-Lymphocyten
ID16083A (id) HIBRID DENGAN INTERFERON DAN IMUNOGLOBULIN Fc YANG DIHUBUNGKAN MELALUI PEPTIDA NON-IMUNOGENIK
DE50210317D1 (de) Peptid zur diagnose und therapie der alzheimer-demenz
SI1105409T1 (sl) Zascita endogenih peptidov pred peptidazno ucinkovitostjo s konjugacijo na krvne komponente
ATE189478T1 (de) Für die reinigung bestimmte klonierung von peptiden
ATE301197T1 (de) Hybridinterferonzusammensetzungen und verfahren zu deren anwendung
NO20002691L (no) IFNAR2/IFN kompleks
TR200003347T2 (tr) Neisseria meningitidis'denBASB029 polinükleotidleri ve polipeptidler
NZ508505A (en) Treatment of wounds using an Egr-1 transcription factor polypeptide
ATE412745T1 (de) Antiangiogene peptide vom n-terminus von endostatin
MY140828A (en) Therapeutic uses of tri-, tetra-, penta-, and polypeptides
NZ500216A (en) Beta-amyloid peptide-binding proteins and pharmaceutical use
ATE42308T1 (de) Pharmakologisch aktive peptide.
TR199902866T2 (xx) Organo- koruyucu aktiviteye sahip yeni BPC peptid tuzlar�, haz�rlanmalar� ve terapide kullan�lmalar� i�in prosesler.
PT938329E (pt) Composicao de tlp imunogenica
AU2676399A (en) Novel cystine knot protein and materials and methods for making it
DE69712182D1 (de) Peptide und ihre verwendung in der therapie von krankheiten des zöliakie-formenkreises
WO2003014293A3 (en) Novel polypeptide analogs and fusions and their methods of use
TR200003345T2 (tr) Moraxella Catarrhalıs'in bileşikleri
DE69534738D1 (de) Leukocyten-aktivierender Faktor
DE69309269D1 (de) Monomere und dimere Peptide, ihre Verwendung zum Schutz von Zellen und ihre Herstellungsverfahren
AU2003274173A1 (en) Peptides and recombinant proteins mimicking interferons
WO2002004005A3 (en) Short peptides comprising histidine or alanine and their therapeutic use
ATE305478T1 (de) Topoisomerase-ii inhibitoren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0759772

Country of ref document: EP

REN Ceased due to non-payment of the annual fee